Diltiazem Uses and Clinical Applications
Diltiazem is primarily indicated for the management of chronic stable angina, angina due to coronary artery spasm, hypertension, and supraventricular tachyarrhythmias. 1, 2
Primary Indications
Cardiovascular Conditions
- Chronic stable angina: First-line or alternative treatment when beta-blockers are contraindicated or not tolerated 1, 3
- Variant angina/coronary artery spasm: Particularly effective due to coronary vasodilatory properties 1, 2
- Hypertension: Effective for blood pressure control 2, 4
- Supraventricular tachyarrhythmias: Particularly useful for rate control in atrial fibrillation with rapid ventricular response 5, 6
Mechanism of Action
Diltiazem is a non-dihydropyridine calcium channel blocker that:
- Inhibits calcium influx through L-type calcium channels in vascular smooth muscle and myocardium 2
- Decreases myocardial oxygen demand by reducing:
- Afterload (peripheral vasodilation)
- Heart rate (negative chronotropic effect)
- Myocardial contractility (negative inotropic effect) 2
- Increases myocardial oxygen supply through coronary artery dilation 3
- Slows sinoatrial and atrioventricular node conduction 2
Clinical Considerations and Precautions
Contraindications
- Decompensated heart failure or severe left ventricular dysfunction 7, 8
- Sick sinus syndrome or advanced AV block (without pacemaker) 7
- Hypotension (systolic BP <90 mmHg) 7
Drug Interactions
- Statins: Moderate increases in exposure when combined with lovastatin or simvastatin; prefer non-CYP3A4-metabolized statins 2
- Beta-blockers: Increased risk of bradycardia and heart block when used in combination 7
- Ivabradine: Should not be used together due to risk of severe bradycardia 2
Adverse Effects
- Bradycardia: Discontinue if heart rate <50 beats/minute 7
- Hypotension: More common with higher doses; consider low-dose regimens (≤0.2 mg/kg IV) for acute situations 6
- AV block: Monitor for conduction abnormalities, especially with concomitant beta-blocker use 5
- Peripheral edema: Common side effect with all calcium channel blockers 2
- Constipation: Particularly with verapamil, less common with diltiazem 2
Special Populations
- Elderly patients: Increased sensitivity to hypotensive effects; start with lower doses 7
- Heart failure: Use with caution; dihydropyridine CCBs (amlodipine, felodipine) are preferred if CCB therapy is necessary 2, 8
Dosing Considerations
Oral dosing:
- Immediate-release: 30 mg every 6 hours or 60 mg every 8 hours
- Extended-release: 120-360 mg once daily
- Typical maintenance dose: 120-360 mg daily (extended release) 7
IV dosing (for rapid atrial fibrillation):
- Traditional dose: 0.25 mg/kg IV bolus over 2 minutes
- Low-dose approach (≤0.2 mg/kg) may be equally effective with lower risk of hypotension 6
Clinical Pearls
- When selecting between calcium channel blockers, diltiazem offers a balance between the pure vasodilatory effects of dihydropyridines and the stronger negative inotropic effects of verapamil 8
- For patients with both hypertension and angina, diltiazem can effectively address both conditions 4
- In patients with non-Q wave myocardial infarction, diltiazem has shown reduction in subsequent cardiac events 5
- Consider electrophysiology study and catheter ablation as definitive treatment for recurrent SVT rather than long-term diltiazem therapy 7
Diltiazem remains a valuable medication in the cardiovascular armamentarium, particularly when beta-blockers are contraindicated or poorly tolerated, though careful monitoring is required especially in patients with compromised left ventricular function.